• Issla Fisher posted an update in the group Group logo of ProductProduct 11 months ago

    The US FDA Has Approved The First Long-Acting Injectable HIV PrEP Medication. The Drug, Called Apretude, Given To Patients Every 2 Months, Is Said To Be 69% More Effective Than The Daily HIV Prevention Pills, Like Truvada and Descovy, For Cisgender Men And Transgender Women Who Have Sex With Men, And 90% More Effective For Cisgender Women.

  • Issla Fisher posted an update in the group Group logo of HealthHealth 2 years, 5 months ago

    Victoria Gray, Age 34, The First Person Treated In The USA With The Gene-Editing Tool Called CRISPR, Is Showing Positive Signs A Year After Her Treatment, Which Comprises Infusing Billions Of Genetically Modified Cells Into Her Body By Doctors. This Appears To Be Alleviating Virtually All Complications Of Her Sickle Cell Disease Disorder.

  • Issla Fisher posted an update in the group Group logo of HealthHealth 3 years, 4 months ago

    A New Drug Implant, Designed To Prevent HIV Infection In High-Risk People Like The Gays, Has Been Developed. The Drug, 10x More Potent Than Any Antiretroviral Medication, Works By Providing Continuous Dose High Enough To Shield Against HIV For A Year, Overcoming Limitations Of Adhering To The Once/Day Pill Regimen Of Truvada.

  • Issla Fisher posted an update in the group Group logo of HealthHealth 3 years, 4 months ago

    Researchers, Using Genome Editing Tool, CRISPR-Cas9, Coupled With The Use Of Long-Acting, Slow-Effective Release ART, Which Can Suppress HIV Cells From Replicating, Were Able To Completely Eliminate HIV In 9 Out Of 23 Mice. This Result, In Mice, May Herald The Complete Elimination Of HIV In Human. Cool!